|
1
|
Lacroix M, Abi-Said D, Fourney DR, et al:
A multivariate analysis of 416 patients with glioblastoma
multiforme: prognosis, extent of resection, and survival. J
Neurosurg. 95:190–198. 2001. View Article : Google Scholar
|
|
2
|
Kanu OO, Hughes B, Di C, et al:
Glioblastoma multiforme oncogenomics and signaling pathways. Clin
Med Oncol. 3:39–52. 2009.PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Minniti G, Salvati M, Arcella A, et al:
Correlation between O6-methylguanine-DNA methyltransferase and
survival in elderly patients with glioblastoma treated with
radiotherapy plus concomitant and adjuvant temozolomide. J
Neurooncol. 102:311–316. 2011. View Article : Google Scholar
|
|
5
|
Watanabe R, Nakasu Y, Tashiro H, et al:
O6-methylguanine DNA methyltransferase expression in tumor cells
predicts outcome of radiotherapy plus concomitant and adjuvant
temozolomide therapy in patients with primary glioblastoma. Brain
Tumor Pathol. 28:127–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin S, Yang J, Lin B, et al: Exome
sequencing identifies frequent mutation of MLL2 in non-small cell
lung carcinoma from Chinese patients. Sci Rep. 4:60362014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leung YK, Mak P, Hassan S and Ho SM:
Estrogen receptor (ER)-beta isoforms: a key to understanding
ER-beta signaling. Proc Natl Acad Sci USA. 103:13162–13167. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burns KA and Korach KS: Estrogen receptors
and human disease: an update. Arch Toxicol. 86:1491–1504. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li LC, Yeh CC, Nojima D and Dahiya R:
Cloning and characterization of human estrogen receptor beta
promoter. Biochem Biophys Res Commun. 275:682–689. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roepke TA, Ronnekleiv OK and Kelly MJ:
Physiological consequences of membrane-initiated estrogen signaling
in the brain. Front Biosci (Landmark Ed). 16:1560–1573. 2011.
View Article : Google Scholar :
|
|
11
|
Liu MM, Albanese C, Anderson CM, et al:
Opposing action of estrogen receptors alpha and beta on cyclin D1
gene expression. J Biol Chem. 277:24353–24360. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bailey ST, Shin H, Westerling T, Liu XS
and Brown M: Estrogen receptor prevents p53-dependent apoptosis in
breast cancer. Proc Natl Acad Sci USA. 109:18060–18065. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nilsson S and Gustafsson JA: Estrogen
receptors: therapies targeted to receptor subtypes. Clin Pharmacol
Ther. 89:44–55. 2011. View Article : Google Scholar
|
|
14
|
Paruthiyil S, Cvoro A, Zhao X, et al: Drug
and cell type-specific regulation of genes with different classes
of estrogen receptor beta-selective agonists. PLoS One.
4:e62712009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suzuki F, Akahira J, Miura I, et al: Loss
of estrogen receptor beta isoform expression and its correlation
with aberrant DNA methylation of the 5′-untranslated region in
human epithelial ovarian carcinoma. Cancer Sci. 99:2365–2372. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mersereau JE, Levy N, Staub RE, et al:
Liquiritigenin is a plant-derived highly selective estrogen
receptor beta agonist. Mol Cell Endocrinol. 283:49–57. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YW, Zhao RJ, Park SJ, et al:
Anti-inflammatory effects of liquiritigenin as a consequence of the
inhibition of NF-kappaB-dependent iNOS and proinflammatory
cytokines production. Br J Pharmacol. 154:165–173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang EJ, Park GH and Song KS:
Neuroprotective effects of liquiritigenin isolated from licorice
roots on glutamate-induced apoptosis in hippocampal neuronal cells.
Neurotoxicology. 39:114–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou M, Higo H and Cai Y: Inhibition of
hepatoma 22 tumor by Liquiritigenin. Phytother Res. 24:827–833.
2010.
|
|
20
|
Sareddy GR, Nair BC, Gonugunta VK, et al:
Therapeutic significance of estrogen receptor beta agonists in
gliomas. Mol Cancer Ther. 11:1174–1182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ryu CH, Yoon WS, Park KY, et al: Valproic
acid downregulates the expression of MGMT and sensitizes
temozolomide-resistant glioma cells. J Biomed Biotechnol.
2012:9874952012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vladusic EA, Hornby AE, Guerra-Vladusic
FK, Lakins J and Lupu R: Expression and regulation of estrogen
receptor beta in human breast tumors and cell lines. Oncol Rep.
7:157–167. 2000.
|
|
23
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shaw RJ and Cantley LC: Ras, PI(3)K and
mTOR signalling controls tumour cell growth. Nature. 441:424–430.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin S, Wang P, Deng W, et al: Dosage
compensation on the active X chromosome minimizes transcriptional
noise of X-linked genes in mammals. Genome Biol. 10:R742009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin S, Deng W, Hu L and Kong X: The impact
of nucleosome positioning on the organization of replication
origins in eukaryotes. Biochem Biophys Res Commun. 385:363–368.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li W, Winters A, Poteet E, et al:
Involvement of estrogen receptor beta5 in the progression of
glioma. Brain Res. 1503:97–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lindberg K, Helguero LA, Omoto Y,
Gustafsson JA and Haldosen LA: Estrogen receptor beta represses Akt
signaling in breast cancer cells via downregulation of HER2/HER3
and upregulation of PTEN: implications for tamoxifen sensitivity.
Breast Cancer Res. 13:R432011. View
Article : Google Scholar
|
|
29
|
Dai C, Zhang B, Liu X, et al: Inhibition
of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity
in pituitary adenoma cell lines in vitro and xenografted pituitary
adenoma in female nude mice. Endocrinology. 154:1247–1259. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Myers MG Jr, Grammer TC, Wang LM, et al:
Insulin receptor substrate-1 mediates phosphatidylinositol
3′-kinase and p70S6k signaling during insulin, insulin-like growth
factor-1, and interleukin-4 stimulation. J Biol Chem.
269:28783–28789. 1994.PubMed/NCBI
|
|
31
|
Jiang BH and Liu LZ: Role of mTOR in
anticancer drug resistance: perspectives for improved drug
treatment. Drug Resist Updat. 11:63–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng WJ, Nie S, Dai J, Wu JR and Zeng R:
Proteome, phosphoproteome, and hydroxyproteome of liver
mitochondria in diabetic rats at early pathogenic stages. Mol Cell
Proteomics. 9:100–116. 2010. View Article : Google Scholar :
|
|
33
|
Gaspar N, Marshall L, Perryman L, et al:
MGMT-independent temozolomide resistance in pediatric glioblastoma
cells associated with a PI3-kinase-mediated HOX/stem cell gene
signature. Cancer Res. 70:9243–9252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Toulany M, Lee KJ, Fattah KR, et al: Akt
promotes post-irradiation survival of human tumor cells through
initiation, progression, and termination of DNA-PKcs-dependent DNA
double-strand break repair. Mol Cancer Res. 10:945–957. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chock KL, Allison JM, Shimizu Y and
ElShamy WM: BRCA1-IRIS overexpression promotes cisplatin resistance
in ovarian cancer cells. Cancer Res. 70:8782–8791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
O’Brien NA, Browne BC, Chow L, et al:
Activated phosphoinositide 3-kinase/AKT signaling confers
resistance to trastuzumab but not lapatinib. Mol Cancer Ther.
9:1489–1502. 2010. View Article : Google Scholar
|
|
37
|
Xu J, Zhou JY, Wei WZ and Wu GS:
Activation of the Akt survival pathway contributes to TRAIL
resistance in cancer cells. PLoS One. 5:e102262010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang SI, Puc J, Li J, et al: Somatic
mutations of PTEN in glioblastoma multiforme. Cancer Res.
57:4183–4186. 1997.PubMed/NCBI
|
